These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21877601)

  • 61. Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.
    Ghanekar A; Kashfi A; Cattral M; Selzner N; McGilvray I; Selzner M; Renner E; Lilly L; Levy G; Grant D; Greig P
    Transplant Proc; 2012 Jun; 44(5):1351-6. PubMed ID: 22664014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial.
    Sheashaa HA; Bakr MA; Ismail AM; Sobh MA; Ghoneim MA
    J Nephrol; 2003; 16(3):393-8. PubMed ID: 12832740
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mycophenolate mofetil in pediatric renal transplantation: non-induction vs. induction with basiliximab.
    Ojogho O; Sahney S; Cutler D; Baron PW; Abdelhalim FM; James S; Zuppan C; Franco E; Concepcion W
    Pediatr Transplant; 2005 Feb; 9(1):80-3. PubMed ID: 15667617
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The role of anti-IL-2 receptor in high-risk kidney transplant patients.
    Jirasiritham S; Sumethkul V; Mavichak V; Lertsithichai P; Jirasiritham S
    Transplant Proc; 2004 Sep; 36(7):2110-2. PubMed ID: 15518764
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Immunosuppression in kidney transplantation].
    Balssa L; Bittard H; Kleinclauss F;
    Prog Urol; 2011 Apr; 21(4):250-3. PubMed ID: 21482398
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induction immunosuppressive therapies in renal transplantation.
    Gabardi S; Martin ST; Roberts KL; Grafals M
    Am J Health Syst Pharm; 2011 Feb; 68(3):211-8. PubMed ID: 21258026
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CDC crossmatch and C1qSCREEN in liver transplantation.
    Focosi D
    Transplantation; 2014 May; 97(10):e61. PubMed ID: 24827896
    [No Abstract]   [Full Text] [Related]  

  • 68. Use of polyclonal/monoclonal antibody therapies in transplantation.
    Yeung MY; Gabardi S; Sayegh MH
    Expert Opin Biol Ther; 2017 Mar; 17(3):339-352. PubMed ID: 28092486
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The authors' reply.
    Kubal CA
    Transplantation; 2014 May; 97(10):e62. PubMed ID: 24827897
    [No Abstract]   [Full Text] [Related]  

  • 70. Immunotherapies in diabetes mellitus type 1.
    Gupta S
    Med Clin North Am; 2012 May; 96(3):621-34, xi. PubMed ID: 22703858
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Anti-thymocyte Globulin Therapy for Cases of Acute Rejection Following Lung Transplantation].
    Karube Y; Ito Y; Nishihira M; Inoue T; Araki O; Maeda S; Kobayashi S; Chida M
    Kyobu Geka; 2016 Oct; 69(11):906-909. PubMed ID: 27713194
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of induction therapy on peripheral blood lymphocytes after lung transplantation: A multicenter international study.
    Coiffard B; Piloni D; Boucekine M; Morosini M; Meloni F; Kessler R; Reynaud-Gaubert M
    Transpl Immunol; 2018 Jun; 48():47-54. PubMed ID: 29475091
    [No Abstract]   [Full Text] [Related]  

  • 73. Immunomodulation in experimental and clinical nephrology using chimeric proteins.
    Kunzendorf U; Pohl T; Bulfone-Paus S; Krause H; Ziegler E; Onu A; Distler A
    Kidney Blood Press Res; 1996; 19(3-4):201-4. PubMed ID: 8887261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Transplantation: it may take two to tango and to treat.
    Martin F
    Immunol Cell Biol; 2008 Feb; 86(2):107-8. PubMed ID: 18180797
    [No Abstract]   [Full Text] [Related]  

  • 75. Kidney transplant drug approved.
    Traynor K
    Am J Health Syst Pharm; 2011 Aug; 68(15):1372. PubMed ID: 21785016
    [No Abstract]   [Full Text] [Related]  

  • 76. Renal allograft rejection: examination of adhesion blockade by antilymphocyte antibody drugs.
    Kirby JA; Lin Y; Browell DA; Clark K; Shenton BK; Forsythe JL; Proud G; Taylor RM
    Nephrol Dial Transplant; 1993; 8(6):544-50. PubMed ID: 8394537
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Belatacept conversion in an HIV-positive kidney transplant recipient following anti-thymocyte globulin induction.
    Kuten SA; Patel SJ; Baru A; Gaber AO; Crutchley RD; Ramanathan V; Knight RJ
    Transpl Infect Dis; 2017 Oct; 19(5):. PubMed ID: 28708266
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Induction therapy in renal transplantation : an overview of current developments.
    Ciancio G; Burke GW; Miller J
    Drugs; 2007; 67(18):2667-80. PubMed ID: 18062717
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A call for transplant stewardship: The need for expanded evidence-based evaluation of induction and biologic-based cost-saving strategies in kidney transplantation and beyond.
    Jorgenson MR; Descourouez JL; Brady BL; Chandran MM; Do V; Kim M; Laub MR; Lichvar A; Park JM; Szczepanik A; Alloway RR
    Clin Transplant; 2021 Sep; 35(9):e14372. PubMed ID: 34033140
    [TBL] [Abstract][Full Text] [Related]  

  • 80. B cell depletion at induction--making bad immunological memory fade?
    Clatworthy MR
    Am J Transplant; 2015 Feb; 15(2):297-8. PubMed ID: 25612482
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.